Elliana Young

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Libero Santarpia, Yuan Qi, Katherine Stemke‐Hale et al. · Breast Cancer Research and Treatment · 2012 · 110 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

Maliazurina B. Saad, Lingzhi Hong, Muhammad Aminu et al. · The Lancet Digital Health · 2023 · 109 citations · Full text

Medicine, Cancer Biology, Oncology +17

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Adam Grippin, Christiano Marconi, Sage Copling et al. · Nature · 2025 · 81 citations · Full text

Life Sciences, Immunology, Oncology +17

Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Onco<i>type</i> DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer

Catherine M. Kelly, Philip S. Bernard, Savitri Krishnamurthy et al. · The Oncologist · 2012 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations

Takayuki Iwamoto, Ju‐Seog Lee, Giampaolo Bianchini et al. · Breast Cancer Research and Treatment · 2011 · 42 citations

Medicine, Bioinformatics, Oncology +17